Know Labs (NYSEAMERICAN:KNW) Stock Price Up 3.8% – Still a Buy?

Know Labs, Inc. (NYSEAMERICAN:KNW) shares traded up 3.8% during trading on Monday . The stock traded as high as $2.17 and last traded at $2.1390. Approximately 612,050 shares were traded during mid-day trading, a decline of 86% from the average session volume of 4,376,964 shares. The stock had previously closed at $2.06.

Know Labs Stock Up 3.8%

The firm has a market capitalization of $16.04 million, a PE ratio of -0.33 and a beta of 1.83. The stock has a 50-day moving average price of $2.14 and a 200 day moving average price of $2.14.

Institutional Investors Weigh In On Know Labs

A hedge fund recently bought a new position in Know Labs stock. Corient Private Wealth LLC acquired a new stake in shares of Know Labs, Inc. (NYSEAMERICAN:KNW) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 50,000 shares of the company’s stock, valued at approximately $99,000. Corient Private Wealth LLC owned approximately 0.67% of Know Labs as of its most recent SEC filing. Institutional investors and hedge funds own 23.96% of the company’s stock.

About Know Labs

Know Labs, Inc (NYSE American: KNW) is a life sciences company developing non‐invasive sensing solutions based on its proprietary Bio‐RFID platform. The technology employs low‐power radio‐frequency spectroscopy to scan the skin, enabling the detection of biochemical markers such as blood glucose, hydration levels and alcohol concentration without the need for blood draws or fingersticks. By applying sophisticated signal‐processing algorithms to reflected electromagnetic waves, the company aims to deliver real‐time, continuous monitoring devices that could transform standard practices in healthcare and wellness.

The company is focused on advancing its flagship prototype devices through clinical validation studies and regulatory pathways.